Our previous study demonstrated that AS-IV prevented ischemia-induced AKI in rats by inhibiting oxidative stress and apoptosis, and the mechanisms of renoprotection by AS-IV were associated with restoring the balance of Bax and Bcl-2 expression and inhibiting caspase-3 and p38 MAPK activation [46]. This evidence concerns the gene BCL2 and ischemia.